CYP19A1 and peripheral neuropathy: Some chemotherapeutic agents, such as platins, bortezomib, taxanes, or vincristine, can cause painful chemotherapy-induced peripheral neuropathy, whereas aromatase inhibitors are associated with diffuse joint pain.